No association between weight gain with integrase inhibitors and diabetes
A large Italian study demonstrated that integrase inhibitor-based antiretroviral therapy was not associated with the risk of developing type 2 diabetes. We also found that baseline weight, rather than weight gain while taking these drugs, was the main factor associated with the development of diabetes. Another study, synthesizing previously published studies on this issue, concluded … Read more
